Radiance Therapeutics to Present at Glaucoma 360 New Horizons Forum

Radiance Therapeutics announced that Laurence Marsteller, MD, Chief Executive Officer, will present the company at the Glaucoma Research Foundation headline event, Glaucoma 360 New Horizons 2023, that will take place on February 3, 2023 in San Francisco.

The Radiance Therapeutics presentation is part of the “Emerging Glaucoma Devices” session to be moderated by Sahar Bedrood, MD, and Tom Samuelson, MD.

Dr. Marsteller will also showcase RadianceTx future development plans for its device, which received a FDA 510(k) clearance on January 11, 2023, at the LSI USA ’23 Emerging Medtech Summit to be held at the Monarch Beach Resort, Dana Point, California from March 20-23 2023.

For additional information about Glaucoma 360 New Horizons 2023, please visit: https://glaucoma.org/events/glaucoma-360

For additional information about LSI USA ’23 Emerging Medtech Summit, please visit: https://www.lifesciencemarketresearch.com/